Overview This page contains the latest trade data of Heterocyclic compounds with unfused imidazole ring,ne. In 2022, Heterocyclic compounds with unfused imidazole ring,ne were the world's 1387th most traded product, with a total trade of $2.24B. Between 2021 and 2022 the exports of Heterocyclic compounds with unfused imidazole ring,ne grew by 11.7%, from $2B to $2.24B. Trade in Heterocyclic compounds with unfused imidazole ring,ne represent 0.0094% of total world trade.
Heterocyclic compounds with unfused imidazole ring,ne are a part of Nitrogen Heterocyclic Compounds.
Exports In 2022 the top exporters of Heterocyclic compounds with unfused imidazole ring,ne were China ($567M), France ($400M), India ($297M), Germany ($171M), and United States ($132M).
Imports In 2022 the top importers of Heterocyclic compounds with unfused imidazole ring,ne were United Kingdom ($291M), United States ($145M), Japan ($131M), Mexico ($130M), and India ($113M).
Ranking Heterocyclic compounds with unfused imidazole ring,ne ranks 236th in the Product Complexity Index (PCI).
Description Imidazole is part of the purine family of heterocyclic compounds. It is found in many natural products, such as histidine and adenosine. Imidazole-based drugs can treat a variety of conditions, including peptic ulcers, Parkinson's disease, and thrombocytopenia.